Assignee
HEXAL AG
DE·40 granted patents·18 pending applications·980 citations·filing 1994–2021
Top patents by PatentIndex Score
58 records- 0192US6284269B1Pharmaceutical compositions of meloxicam with improved solubility and bioavailabilityHEXAL AG·Filed 1998·Granted Sep 4, 2001·246 cites·22 claims
- 0289US6248758B1Pharmaceutical antacidHEXAL AG·Filed 1998·Granted Jun 19, 2001·108 cites·28 claims
- 0389US6022852APharmaceutical composition containing cyclosporin AHEXAL AG·Filed 1998·Granted Feb 8, 2000·92 cites·6 claims
- 0483US7344733B2Matrix controlled transdermal therapeutic system for the use of pramipexole and ropiniroleHEXAL AG·Filed 2002·Granted Mar 18, 2008·39 cites·13 claims
- 0583US6623752B1Patch for transdermal application for pergolidHEXAL AG·Filed 2000·Granted Sep 23, 2003·24 cites·8 claims
- 0682US6303141B1Transdermally administrable medicament with ACE inhibitorsHEXAL AG·Filed 1999·Granted Oct 16, 2001·53 cites·22 claims
- 0779US7220473B2Absorbing agents and cover layer which is impermeable to active substances and which contains channel-formers or removable protective layer of a transdermal therapeutic systemHEXAL AG·Filed 2001·Granted May 22, 2007·23 cites·8 claims
- 0876US5856359AThyroxine/cyclodextrin complexes and pharmaceutical compositions containing the sameHEXAL AG·Filed 1996·Granted Jan 5, 1999·47 cites·16 claims
- 0975US6579536B1Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredientHEXAL AG·Filed 1999·Granted Jun 17, 2003·56 cites·13 claims
- 1074US5738869ATransdermal drug preparationHEXAL AG·Filed 1994·Granted Apr 14, 1998·54 cites·7 claims
- 1171US6267990B1Controlled-release pharmaceutical preparation comprising an ACE inhibitor as active ingredientHEXAL AG·Filed 1999·Granted Jul 31, 2001·35 cites·36 claims
- 1271US5904930ATransdermal system in the form of a patch comprising a tamoxifen derivativeHEXAL AG·Filed 1997·Granted May 18, 1999·37 cites·14 claims
- 1370US11123300B2Immediate release tablet of a benzothiophene compoundHEXAL AG·Filed 2017·Granted Sep 21, 2021·1 cites·17 claims
- 1469US6395297B1Transdermal preparation contacting a loratidine metabolite with antihistaminic activityHEXAL AG·Filed 2000·Granted May 28, 2002·1 cites·10 claims
- 1566US6696413B2Pharmaceutical preparation with cyclosporin AHEXAL AG·Filed 1998·Granted Feb 24, 2004·26 cites·28 claims
- 1663US2008113012A1Method for using transdermal system with fentanylHEXAL AG·Filed 2008·Application pending·0 cites
- 1762US9789112B2Oral pharmaceutical film formulation for bitter tasting drugsHEXAL AG·Filed 2016·Granted Oct 17, 2017·1 cites·22 claims
- 1862US6537970B1Pharmaceutical compositionHEXAL AG·Filed 1998·Granted Mar 25, 2003·31 cites·12 claims
- 1958US2018067124A1Method of mapping glycans of glycoproteinsHEXAL AG·Filed 2017·Application pending·0 cites
- 2055US2022119471A1Glycoprotein with reduced acetylation rate of sialic acid residuesHEXAL AG·Filed 2021·Application pending·0 cites
- 2154US7690494B2Conveyor device having a filling device for vertical flow of material, without demixing, of powdered mediaHEXAL AG·Filed 2005·Granted Apr 6, 2010·7 cites·3 claims
- 2253US5972376ATransdermal system of tacrine/selegilin-plasterHEXAL AG·Filed 1996·Granted Oct 26, 1999·15 cites·25 claims
- 2353US2004001882A1Transdermal system with fentanylHEXAL AG·Filed 2003·Application pending·0 cites
- 2450US5874107ASustained release tablet containing diclofenac-Na and methylhydroxypropyl-cellulose as a sustained release agentHEXAL AG·Filed 1995·Granted Feb 23, 1999·12 cites·5 claims
- 2549USD600353SCovering materialHEXAL AG·Filed 2006·Granted Sep 15, 2009·7 cites·1 claims
- 2648US9895497B2Method for reducing leachables and extractables in syringesHEXAL AG·Filed 2014·Granted Feb 20, 2018·0 cites·7 claims
- 2748US6440513B1Flat transdermal medicated self-adhesive patchHEXAL AG·Filed 1997·Granted Aug 27, 2002·26 cites·23 claims
- 2846US5989585ATransdermal therapeutic system (TTS) containing vitamin E for the treatment of drug dependencyHEXAL AG·Filed 1996·Granted Nov 23, 1999·12 cites·12 claims
- 2946US2009186341A1Receptacle for the Separation of Tumor CellsHEXAL AG·Filed 2006·Application pending·0 cites
- 3045US2024052030A1Novel formulations for antibodiesHEXAL AG·Filed 2021·Application pending·0 cites
- 3144US10485799B2Pharmaceutical composition of vortioxetine hydrobromide comprising vortioxetine hydrobromide in a polyethylene oxide matrixHEXAL AG·Filed 2016·Granted Nov 26, 2019·0 cites·9 claims
- 3244US6204255B1Solid, non-deliquescent formulations of sodium valproateHEXAL AG·Filed 1998·Granted Mar 20, 2001·7 cites·14 claims
- 3344US2018042861A1Transdermal therapeutic system comprising buprenorphrineHEXAL AG·Filed 2017·Application pending·0 cites
- 3444US2016151484A1Methods and formulations which allow the modulation of immune responses related to the administration of a biopharmaceutical drugHEXAL AG·Filed 2014·Application pending·0 cites
- 3543US11072605B2Crystalline brexpiprazoleHEXAL AG·Filed 2018·Granted Jul 27, 2021·0 cites·12 claims
- 3642US10668073B2Pharmaceutical composition containing 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione or a pharmaceutically acceptable salt thereofHEXAL AG·Filed 2016·Granted Jun 2, 2020·0 cites·17 claims
- 3741US2016199293A1Method for manufacturing an ingestible film, apparatus for manufacturing an ingestible film, ingestible film and pharmaceutical dosage form comprising the sameHEXAL AG·Filed 2014·Application pending·0 cites
- 3840US2019025323A1Methods of Mapping Protein VariantsHEXAL AG·Filed 2017·Application pending·0 cites
- 3939USD634850SCovering materialHEXAL AG·Filed 2007·Granted Mar 22, 2011·3 cites·1 claims
- 4039US2015366807A1Oral pharmaceutical composition comprising dabigatran etexilateHEXAL AG·Filed 2013·Application pending·0 cites
- 4139US2009023714A1Combined preparation of a thiazide diuretic and a loop diureticHEXAL AG·Filed 2006·Application pending·0 cites
- 4238US6071964ADiclofenac/gamma-cyclodextrin inclusion compoundsHEXAL AG·Filed 1997·Granted Jun 6, 2000·9 cites·14 claims
- 4337US6165498ATransdermal preparation containing a loratidine metabolite with antihistaminic activityHEXAL AG·Filed 1995·Granted Dec 26, 2000·3 cites·6 claims
- 4437US2019177385A1Glycoprotein with reduced acetylation rate of sialic acid residuesHEXAL AG·Filed 2017·Application pending·0 cites
- 4537US2017205423A1Method of Mapping Glycans of Glycoproteins in Serum SamplesHEXAL AG·Filed 2015·Application pending·0 cites
- 4636USD636882SCovering materialHEXAL AG·Filed 2010·Granted Apr 26, 2011·2 cites·1 claims
- 4734US9717707B2Pharmaceutical statin compositionHEXAL AG·Filed 2012·Granted Aug 1, 2017·0 cites·21 claims
- 4834US2016129113A1Tablets comprising a taste masking agentHEXAL AG·Filed 2015·Application pending·0 cites
- 4934US2014363516A1Multiple unit pellet tablet formulation comprising an opioidHEXAL AG·Filed 2012·Application pending·0 cites
- 5032US11021530B2Antibody preparationHEXAL AG·Filed 2017·Granted Jun 1, 2021·0 cites·8 claims
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when HEXAL AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →